Mateus N Aoki
Overview
Explore the profile of Mateus N Aoki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murray K, Oldfield L, Stefanova I, Gentiluomo M, Aretini P, OSullivan R, et al.
Semin Cancer Biol
. 2025 Feb;
111:76-88.
PMID: 39986585
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed in its late stages when treatment options are limited. Unlike other common cancers, there are no population-wide screening programmes for PDAC. Thus, early...
2.
Giaccherini M, Giaccherini M, Rende M, Gentiluomo M, Gentiluomo M, Corradi C, et al.
Mutagenesis
. 2024 Apr;
PMID: 38606763
Pleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to...
3.
Conzentino M, Goncalves A, Paula N, Rego F, Zanette D, Aoki M, et al.
Braz J Microbiol
. 2022 Apr;
53(3):1263-1269.
PMID: 35426068
Immunological assays to detect SARS-CoV-2 Spike Receptor Binding Domain (RBD) antigen seroconversion in humans are important tools to monitor the levels of protecting antibodies in the population in response to...
4.
Conzentino M, Santos T, Selim K, Wagner B, Alford J, Deobald N, et al.
Anal Biochem
. 2021 Sep;
631:114360.
PMID: 34481802
To monitor the levels of protecting antibodies raised in the population in response to infection and/or to immunization with SARS-CoV-2, we need a technique that allows high throughput and low-cost...
5.
Conzentino M, Forchhammer K, Souza E, Pedrosa F, Nogueira M, Raboni S, et al.
Braz J Microbiol
. 2021 Aug;
52(4):2069-2073.
PMID: 34342836
Serological assays are important tools to identify previous exposure to SARS-CoV-2, helping to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or immunization to future...
6.
Huergo L, Selim K, Conzentino M, Gerhardt E, Santos A, Wagner B, et al.
ACS Sens
. 2021 Jan;
6(3):703-708.
PMID: 33496577
Immunological methods to detect SARS-CoV-2 seroconversion in humans are important to track COVID-19 cases and the humoral response to SARS-CoV-2 infections and immunization to future vaccines. The aim of this...
7.
Aoki M, Amarante M, de Oliveira C, Watanabe M
Anticancer Agents Med Chem
. 2018 Aug;
18(15):2070-2077.
PMID: 30147015
Introduction: The understanding of cancer has evolved into a complex disease, which has heterogeneous characteristics between different patients, and more than that, a broad range of genetically distinct cells in...